Ralph L. Henry

Ralph L. Henry

Distinguished Professor

J. William Fulbright College of Arts & Sciences

(BISC)-Biological Sciences

Phone: 479-575-3251

Download vcard


Visit Website

Download CV

Dr. Henry is a Distinguished Professor at the University of Arkansas in Biological Sciences and the Institute for Nano-scale Science and Engineering. His research is focused on protein targeting, protein production technologies, and development of protein therapies to treat methamphetamine addiction.  Henry is a co-founder and VP Biopharmaceutics at InterveXion Therapeutics where his efforts support interactions with FDA, manufacturing and testing of InterveXion’s protein therapies, and oversight of these therapies in human clinical trials.  Patents resulting from his work support InterveXion (intervexion.com)and another Arkansas-based start-up, Boston Mountain Biotech (mtnbio.com).  Dr. Henry holds the WM Keck Professorship in Biological Sciences.

Protein Targeting, Protein Production Technologies, Medications Development, Entrepreneurship

Cell Biology, Medications Development Process, Plant Physiology, Biology Careers

  • University of Kansas,  BSE      1979-1984
  • Kansas State University, MS    1984-1987   
  • Kansas State University, PhD  1987-1991  
  • University of Florida, Postdoc  1992-1996  

A full list of publications and patents can be viewed at http://www.uark.edu/ua/henrylab/


  • 2004-present     VP Biopharmaceutics, InterveXion Therapeutics, LLC
  • 2012-present     Distinguished Professor, Biological Sciences, University of Arkansas
  • 2005-present     Professor, Biological Sciences, University of Arkansas
  • 2002-2005         Associate Professor, Biological Sciences, Univeristy of Arkansas
  • 1996-2002         Assistant Professor, Biological Sciences, University of Arkansas 
  • WM Keck Endowed Professorship, Awarded February, 2013
  • Inaugural member National Academy of Inventors, May 2013
  • Fellow, South East Conference Academic Leadership Program (2009-2010)